Growth Metrics

Idexx Laboratories (IDXX) Return on Equity (2016 - 2025)

Idexx Laboratories has reported Return on Equity over the past 16 years, most recently at 0.67% for Q4 2025.

  • Quarterly results put Return on Equity at 0.67% for Q4 2025, up 12.0% from a year ago — trailing twelve months through Dec 2025 was 0.67% (up 12.0% YoY), and the annual figure for FY2025 was 0.66%, up 9.0%.
  • Return on Equity for Q4 2025 was 0.67% at Idexx Laboratories, down from 0.68% in the prior quarter.
  • Over the last five years, Return on Equity for IDXX hit a ceiling of 1.44% in Q3 2022 and a floor of 0.54% in Q2 2024.
  • Median Return on Equity over the past 5 years was 0.75% (2023), compared with a mean of 0.85%.
  • Biggest five-year swings in Return on Equity: tumbled -205bps in 2021 and later skyrocketed 43bps in 2022.
  • Idexx Laboratories' Return on Equity stood at 1.03% in 2021, then rose by 21bps to 1.25% in 2022, then crashed by -51bps to 0.61% in 2023, then dropped by -9bps to 0.55% in 2024, then increased by 21bps to 0.67% in 2025.
  • The last three reported values for Return on Equity were 0.67% (Q4 2025), 0.68% (Q3 2025), and 0.68% (Q2 2025) per Business Quant data.